Clinical Trials Browser

Phase 1 × Neoplasms × STA 9090 × Clear all

NCT02192541 2018-03-29

Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas

Phase 1 Terminated

5 enrolled 15 charts

Neoplasms, Sarcoma

NCT01183364 2014-09-19

A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors

Phase 1 Completed

Neoplasms